







To find out why GuruFocus thinks data on insider trade are interesting, read
| Symbol | Company | Insider | Position | Date | Buy/Sell | Shares | Trade Price ($) | Cost ($1000) | Price Change Since Trade (%) |
Yield (%) | P/E | Market Cap ($M) | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
![]() | BMRN | Biomarin Pharma... | FUCHS HENRY J | EVP, Chief Medical Officer | 2013-06-03 | Sell | 1,098 | $58.32 | 64 | -0.19 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | FUCHS HENRY J | EVP, Chief Medical Officer | 2013-05-23 | Sell | 20,609 | $66.29 | 1366.2 | -12.19 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Wood Mark | VP, Human Resources | 2013-05-22 | Sell | 3,103 | $67.12 | 208.3 | -13.27 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO (Click for the stocks that their CEOs have bought) | 2013-05-21 | Sell | 2,000 | $64.14 | 128.3 | -9.25 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-13 | Sell | 15,800 | $68.77 | 1086.6 | -15.36 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-16 | Sell | 12,000 | $67.9 | 814.8 | -14.27 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-14 | Sell | 15,000 | $70.17 | 1052.6 | -17.04 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-14 | Sell | 25,000 | $70.94 | 1773.5 | -17.94 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BAFFI ROBERT | EVP, Technical Operations | 2013-05-14 | Sell | 20,000 | $70 | 1400 | -16.84 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Davis George Eric | SVP, General Counsel | 2013-05-14 | Sell | 20,000 | $70.34 | 1406.8 | -17.24 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Mueller Brian | VP, Corporate Controller | 2013-05-14 | Sell | 4,947 | $70.35 | 348 | -17.26 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 2013-05-13 | Sell | 1,248 | $69.26 | 86.4 | -15.95 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-13 | Sell | 15,800 | $68.77 | 1086.6 | -15.36 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Davis George Eric | SVP, General Counsel | 2013-05-13 | Sell | 2,590 | $69.29 | 179.5 | -15.99 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-08 | Sell | 4,000 | $65.87 | 263.5 | -11.63 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Davis George Eric | SVP, General Counsel | 2013-05-03 | Sell | 5,854 | $67.19 | 393.3 | -13.37 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BAFFI ROBERT | EVP, Technical Operations | 2013-05-03 | Sell | 20,000 | $67 | 1340 | -13.12 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-03 | Sell | 8,000 | $67.24 | 537.9 | -13.43 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Mueller Brian | VP, Corporate Controller | 2013-05-03 | Sell | 16,831 | $66.17 | 1113.7 | -12.03 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | SPIEGELMAN DANIEL K | EVP, CFO | 2013-05-01 | Sell | 28,000 | $64.42 | 1803.8 | -9.64 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-05-02 | Sell | 3,000 | $64.99 | 195 | -10.43 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | FUCHS HENRY J | EVP, Chief Medical Officer | 2013-04-30 | Sell | 20,000 | $63.29 | 1265.8 | -8.03 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Wood Mark | VP, Human Resources | 2013-04-22 | Sell | 3,102 | $65.57 | 203.4 | -11.22 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Ajer Jeffrey Robert | SVP, Chief Commercial Of | 2013-04-19 | Sell | 5,000 | $65 | 325 | -10.45 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BAFFI ROBERT | EVP, Technical Operations | 2013-04-10 | Sell | 20,000 | $64 | 1280 | -9.05 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BIENAIME JEAN JACQUES | CEO | 2013-03-26 | Sell | 12,000 | $60.68 | 728.2 | -4.07 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | Wood Mark | VP, Human Resources | 2013-03-22 | Sell | 3,103 | $60.21 | 186.8 | -3.32 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BAFFI ROBERT | EVP, Technical Operations | 2010-03-10 | Sell | 163,888 | $22.52 | 3690.8 | 158.48 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | BAFFI ROBERT | EVP, Technical Operations | 2013-03-18 | Sell | 20,000 | $61.02 | 1220.4 | -4.61 | 0.00 | 0.00 | 8086.22 | |
![]() | BMRN | Biomarin Pharma... | GREY MICHAEL G | Director | 2013-03-06 | Sell | 15,000 | $60.61 | 909.2 | -3.96 | 0.00 | 0.00 | 8086.22 |
| Guru Name | Portfolio Date* | Current Shares (?) | % of Total Assets (?) | Change from Last Holdings (?) | |
|---|---|---|---|---|---|
| Frank Sands | 2013-03-31 | 10,951,298 | 2.4% | +10.9% | |
| John Griffin | 2013-03-31 | 1,750,000 | 1.4% | ||
| Columbia Wanger | 2013-03-31 | 3,105,000 | 0.84% | -45.27% | |
| PRIMECAP Management | 2013-03-31 | 7,743,329 | 0.71% | -4.41% | |
| Steven Cohen | 2013-03-31 | 1,491,591 | 0.45% | -38.49% | |
| RS Investment Management | 2013-03-31 | 264,060 | 0.12% | +52.33% | |
| Meridian Funds | 2013-03-31 | 40,700 | 0.09% | -69.03% | |
| Jim Simons | 2013-03-31 | 53,471 | 0.01% | New Buy | |
| Pioneer Investments | 2013-03-31 | 0 | 0% | Sold Out | |
Most recent portfolio changes are included for Premium Members only!
| |||||
Add Notes, Comments or Ask Questions
Comments